Healthcare, biotechnology & medical AI Product
Neurophet SCALE PET and AQUA quantify different kinds of brain images
Neurophet SCALE PET supports review of specified brain PET scans. Neurophet AQUA labels and measures structures visible on brain MRI under a separate clearance. [1][2]
What it does
The FDA cleared Neurophet SCALE PET under K221405 on August 5, 2022, and Neurophet AQUA under K261273 on May 15, 2026. [1][2]
Why it matters
The two decisions differentiate a PET analysis tool from an MRI structural analysis tool. The software names identify which outputs the filing describes. [1][2]
Who it’s for
The documented outputs support healthcare professionals reviewing the specified brain imaging studies. [1][2]
Key dates
Where it fits
SCALE PET presents quantitative information from supported PET studies. AQUA provides visualizations and volume measurements from MRI. [1][2]
Limits and trade-offs
The decisions apply to the named imaging modalities and labeled functions of each product. [1][2]
Sources and verification
Catalog evidence checked How we verify records
- Primary source FDA 510(k) decision for Neurophet AQUA (K261273)
- Primary source FDA 510(k) decision for Neurophet SCALE PET (K221405)
Related profiles
Healthcare, biotechnology & medical AI
Sleep Analysis Module (SAM)
Neurotronics (Nihon Kohden)
The module estimates sleep time from a signal captured during its intended sleep-testing workflow.
Healthcare, biotechnology & medical AI
Heartvue.Proton
Heartvue.ai
It is software for analyzing cardiac MRI images within its documented intended-use scope.
Healthcare, biotechnology & medical AI
ThinkSono Guidance
ThinkSono
Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.